The Leap Fund will back early-stage, risky research that would not be able to secure funding through other channels.
UK-based charitable foundation Wellcome Trust announced the £250m ($330m) Leap Fund today to help accelerate research commercialisation originating from universities and companies.
The fund will launch operations from 2020, running for an initial five years and making up approximately 5% of Wellcome’s charitable investments during that period.
The fund will hire a chief executive within the next few months. The CEO will enjoy a significant amount of freedom, working with external community and having the authority to shape the portfolio,…
